**Question:** Sumatriptan is contraindicated in

A. migraine patients with cardiovascular risk factors
B. migraine patients with a history of stroke
C. migraine patients with a history of myocardial infarction
D. migraine patients with a history of severe asthma

**Correct Answer:** B. migraine patients with a history of stroke

**Core Concept:** Sumatriptan is a selective 5-HT1B/1D receptor agonist, primarily used for the acute treatment of migraine. It works by constricting the blood vessels in the brain, reducing inflammation, and decreasing the production of neurotransmitters that contribute to migraine pain. Contraindications are conditions that prevent a patient from receiving the medication, as it can potentially worsen the patient's condition or increase the risk of adverse events.

**Why the Correct Answer is Right:** Sumatriptan is contraindicated in patients with a history of stroke because these patients have a higher risk of experiencing another stroke while taking sumatriptan. Strokes are caused by blood vessel blockage or rupture in the brain, leading to brain cell damage and neurological deficits. Sumatriptan, as a vasoconstrictor, increases the risk of ischemic stroke in patients with pre-existing cerebrovascular disease or those with a history of transient ischemic attacks (TIAs).

**Why Each Wrong Option is Incorrect:**

A. Migraine patients with cardiovascular risk factors: Although sumatriptan can be used in patients with cardiovascular risk factors, the focus should be on carefully assessing these patients to rule out significant cardiovascular disease before prescribing sumatriptan. Patients with risk factors like hypertension, diabetes, or dyslipidemia should be evaluated further as individual cases, and treatment can be considered if no significant cardiovascular disease is found.

C. Migraine patients with a history of myocardial infarction (heart attack): Sumatriptan is contraindicated in patients with a history of myocardial infarction due to the increased risk of cardiovascular complications. In these patients, sumatriptan can lead to myocardial ischemia, arrhythmias, or stroke.

D. Migraine patients with a history of severe asthma: There is no direct relation between severe asthma and sumatriptan contraindications. While asthma is a respiratory condition, sumatriptan is a CNS medication, and its contraindications are related to cerebrovascular events. Asthma patients can still receive sumatriptan, provided they have no risk factors for cerebrovascular events.

**Clinical Pearl:** When selecting a medication for migraine treatment, consider individual patient characteristics, such as cardiovascular risk factors, previous cerebrovascular events, and severe respiratory conditions like asthma. Always assess the patient's medical history and perform a thorough physical examination before prescribing sumatriptan or any other medication to ensure the safest treatment options for patients.